TARS Competitors & Alternatives
Compare Tarsus Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
TARS
Main Stock$66.17
Tradestie Score
61
Market Cap
$2.42B
Revenue Growth
1.1%
Analyst Upside
+42.2%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CNTA
Centessa Pharmaceuticals plc American Depositary Shares
|
$40.50
|
$3.03B | - | 61 | Compare |
|
XENE
Xenon Pharmaceuticals Inc
|
$54.61
|
$3.02B | - | 67 | Compare |
|
CGON
CG Oncology, Inc. Common stock
|
$65.73
|
$3.01B | - | 55 | Compare |
|
APLS
Apellis Pharmaceuticals, Inc. Common Stock
|
$41.03
|
$2.92B | 38.3 | 59 | Compare |
|
RARE
Ultragenyx Pharmaceutical Inc.
|
$28.76
|
$2.89B | - | 64 | Compare |
|
IMVT
Immunovant, Inc. Common Stock
|
$37.62
|
$2.85B | - | 58 | Compare |
|
CPRX
Catalyst Pharmaceutical Inc.
|
$31.40
|
$2.56B | 18.1 | 55 | Compare |
|
CDTX
Cidara Therapeutics, Inc.
|
$221.38
|
$2.44B | - | 57 | Compare |
|
BEAM
Beam Therapeutics Inc. Common Stock
|
$33.20
|
$2.44B | - | 63 | Compare |
|
BLTE
Belite Bio, Inc American Depositary Shares
|
$145.09
|
$2.41B | - | 62 | Compare |
More TARS Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry